skip to Main Content

North American Prodromal Synucleinopathy Consortium


Brief Summary:

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior
disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective
treatments against synucleinopathies.


Inclusion Criteria:

– Idiopathic REM sleep behavior disorder

Exclusion Criteria:

– REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia,
Parkinson’s Disease, etc)

– Other neurological disorder


  • University of California Los Angeles, Los Angeles, California, United States, 90095
  • Stanford University, Redwood City, California, United States, 94063
Back To Top